Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Lewis, D. A. Articles by Pierri, J. N. Search for Related Content PubMed Citation Articles by Lewis, D. A. Articles by Pierri, J. N. Neurophysiology Schizophrenia Spectrum Disorders

Lamina-Specific Deficits in Parvalbumin-Immunoreactive Varicosities in the Prefrontal Cortex of Subjects With Schizophrenia: Evidence for Fewer Projections From the Thalamus

OBJECTIVE: Neuronal number in the mediodorsal thalamic nucleus, the principal source of thalamic projections to the prefrontal cortex, has been reported to be lower in subjects with schizophrenia. The authors tested the hypothesis that schizophrenia is associated with a selective deficit in a marker of thalamic axon terminals in the middle layers of the prefrontal cortex, the primary zone of termination of thalamic axons. METHOD: The densities of parvalbumin-immunoreactive varicosities (putative axon terminals) were determined in the superficial and middle layers of prefrontal cortex area 9 from 20 matched pairs of subjects with schizophrenia and normal comparison subjects. In order to determine the specificity of these observations, similar studies were conducted in subjects with major depressive disorder and in monkeys after 9–12 months of haloperidol treatment. RESULTS: The relative densities of parvalbumin-immunoreactive varicosities did not differ between schizophrenic and comparison subjects in the superficial layers. However, in the middle layers, mean varicosity density was significantly lower (24% difference) in the subjects with schizophrenia. In contrast, neither subjects with major depressive disorder nor haloperidol-treated monkeys exhibited a middle-layer density of parvalbumin-immunoreactive varicosities that was lower than that of their matched comparison groups. CONCLUSIONS: Although not definitive, these findings are consistent with the hypothesis of fewer projections from the mediodorsal thalamic nucleus to the prefrontal cortex in schizophrenic subjects and thus converge with other lines of evidence demonstrating an abnormality in thalamo-prefrontal cortical circuitry in persons with schizophrenia.

This article has been cited by other articles:

				G. Gonzalez-Burgos and D. A. Lewis GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia Schizophr Bull, September 1, 2008; 34(5): 944 - 961. [Abstract] [Full Text] [PDF]

				D. Vierling-Claassen, P. Siekmeier, S. Stufflebeam, and N. Kopell Modeling GABA Alterations in Schizophrenia: A Link Between Impaired Inhibition and Altered Gamma and Beta Range Auditory Entrainment J Neurophysiol, May 1, 2008; 99(5): 2656 - 2671. [Abstract] [Full Text] [PDF]

				E. K. Lambe, R.-J. Liu, and G. K. Aghajanian Schizophrenia, Hypocretin (Orexin), and the Thalamocortical Activating System Schizophr Bull, November 1, 2007; 33(6): 1284 - 1290. [Abstract] [Full Text] [PDF]

				J. J. Cerqueira, R. Taipa, H. B. M. Uylings, O. F. X. Almeida, and N. Sousa Specific Configuration of Dendritic Degeneration in Pyramidal Neurons of the Medial Prefrontal Cortex Induced by Differing Corticosteroid Regimens Cereb Cortex, September 1, 2007; 17(9): 1998 - 2006. [Abstract] [Full Text] [PDF]

				N. Pillai-Nair, A. K. Panicker, R. M. Rodriguiz, K. L. Gilmore, G. P. Demyanenko, J. Z. Huang, W. C. Wetsel, and P. F. Maness Neural Cell Adhesion Molecule-Secreting Transgenic Mice Display Abnormalities in GABAergic Interneurons and Alterations in Behavior J. Neurosci., May 4, 2005; 25(18): 4659 - 4671. [Abstract] [Full Text] [PDF]

				E. M. Kemether, M. S. Buchsbaum, W. Byne, E. A. Hazlett, M. Haznedar, A. M. Brickman, J. Platholi, and R. Bloom Magnetic Resonance Imaging of Mediodorsal, Pulvinar, and Centromedian Nuclei of the Thalamus in Patients With Schizophrenia Arch Gen Psychiatry, October 1, 2003; 60(10): 983 - 991. [Abstract] [Full Text] [PDF]

				T. Hashimoto, D. W. Volk, S. M. Eggan, K. Mirnics, J. N. Pierri, Z. Sun, A. R. Sampson, and D. A. Lewis Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia J. Neurosci., July 16, 2003; 23(15): 6315 - 6326. [Abstract] [Full Text] [PDF]

				J. R. Highley, M. A. Walker, T. J. Crow, M. M. Esiri, and P. J. Harrison Low Medial and Lateral Right Pulvinar Volumes in Schizophrenia: A Postmortem Study Am J Psychiatry, June 1, 2003; 160(6): 1177 - 1179. [Abstract] [Full Text] [PDF]

				A. C. Grobin, E. J. Heenan, J. A. Lieberman, and A. L. Morrow Perinatal Neurosteroid Levels Influence GABAergic Interneuron Localization in Adult Rat Prefrontal Cortex J. Neurosci., March 1, 2003; 23(5): 1832 - 1839. [Abstract] [Full Text] [PDF]

				P. J. Harrison The neuropathology of primary mood disorder Brain, July 1, 2002; 125(7): 1428 - 1449. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us